Home >> Life Sciences >> Pharmaceuticals

2017-2022 North America Head Lice Infestation Drug Market Report

Published: Jan-2018 | Format: PDF | LPI (LP Information) | Number of pages: 113 | Code: MRS - 198974

In 2016, the North America Head Lice Infestation Drug market size was xx million and it will reach xx million in 2022, with a CAGR of xx% between 2016 and 2022.

This report studies Head Lice Infestation Drug in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering
    Bayer
    Omega Pharma
    Thornton and Ross
    Prestige Brands
    Perrigo
    Actavis
    Reckitt Benckier
    Tyratech
    Shionogi
    TecLabs
    Arborpharma
    Major Pharmaceuticals
    Logic Products
    Tianren
    ParaPRO

Market Segment by Countries, this report splits North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 (forecast), like
    United States
    Canada
    Mexico

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
    Lotion
    Creams
    Shampoo
    Other

Split by applications, this report focuses on sales, market share and growth rate of Head Lice Infestation Drug in each application, can be divided into
    Children
    Adult
Table of Contents

2017-2022 North America Head Lice Infestation Drug Market Report
1 Head Lice Infestation Drug Market Overview
    1.1 Product Overview and Scope of Head Lice Infestation Drug
    1.2 Head Lice Infestation Drug Segment by Types
        1.2.1 North America Sales Market Share of Head Lice Infestation Drug by Types in 2016
        1.2.2 Lotion
            1.2.2.1 Major Players of Lotion
        1.2.3 Creams
            1.2.3.1 Major Players of Creams
        1.2.4 Shampoo
            1.2.4.1 Major Players of Shampoo
        1.2.5 Other
            1.2.5.1 Major Players of Other
    1.3 Head Lice Infestation Drug Segment by Applications
        1.3.1 Head Lice Infestation Drug Sales Market Share by Applications in 2016
        1.3.2 Children
        1.3.3 Adult
    1.4 Head Lice Infestation Drug Market by Countries
        1.4.1 United States Status and Prospect (2012-2022)
        1.4.2 Canada Status and Prospect (2012-2022)
        1.4.3 Mexico Status and Prospect (2012-2022)
    1.5 North America Head Lice Infestation Drug Overview and Market Size (Value) (2012-2022)
        1.5.1 North America Market Head Lice Infestation Drug Overview
        1.5.2 North America Market Head Lice Infestation Drug Revenue (Million USD) and Growth Rate (2012-2022)
2 North America Head Lice Infestation Drug Sales, Revenue (Value) and Market Share by Players
    2.1 North America Head Lice Infestation Drug Sales and Market Share in 2016 and 2017 by Players
    2.2 North America Head Lice Infestation Drug Revenue and Market Share by Players in 2016 and 2017
    2.3 North America Head Lice Infestation Drug Average Price by Players in 2016 and 2017
    2.4 North America Head Lice Infestation Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
    2.5 Head Lice Infestation Drug Market Competitive Situation and Trends
        2.5.1 Head Lice Infestation Drug Market Concentration Rate
        2.5.2 Head Lice Infestation Drug Market Share of Top 3 and Top 5 Players
        2.5.3 Mergers & Acquisitions, Expansion
3 North America Head Lice Infestation Drug Sales, Revenue (Value) by Countries, Type and Application (2012-2017)
    3.1 North America Head Lice Infestation Drug Sales, Revenue and Market Share by Countries (2012-2017)
        3.1.1 North America Head Lice Infestation Drug Sales and Market Share by Countries (2012-2017)
        3.1.2 North America Head Lice Infestation Drug Revenue and Market Share by Countries (2012-2017)
        3.1.3 North America Head Lice Infestation Drug Price by Countries (2012-2017)
    3.2 North America Head Lice Infestation Drug Sales, Revenue, Market Share and Price by Type (2012-2017)
        3.2.1 North America Head Lice Infestation Drug Sales and Market Share by Type (2012-2017)
        3.2.2 North America Head Lice Infestation Drug Revenue and Market Share by Type (2012-2017)
        3.2.3 North America Head Lice Infestation Drug Price by Type (2012-2017)
    3.3 North America Head Lice Infestation Drug Sales and Market Share by Application (2012-2017)
    3.4 North America Market Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4 North America Head Lice Infestation Drug Players Profiles/Analysis
    4.1 Bayer
        4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.1.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.1.2.1 Type 1
            4.1.2.2 Type 2
        4.1.3 Bayer Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.1.4 Main Business/Business Overview
        4.1.5 Bayer News
    4.2 Omega Pharma
        4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.2.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.2.2.1 Type 1
            4.2.2.2 Type 2
        4.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.2.4 Main Business/Business Overview
        4.2.5 Omega Pharma News
    4.3 Thornton and Ross
        4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.3.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.3.2.1 Type 1
            4.3.2.2 Type 2
        4.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.3.4 Main Business/Business Overview
        4.3.5 Thornton and Ross News
    4.4 Prestige Brands
        4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.4.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.4.2.1 Type 1
            4.4.2.2 Type 2
        4.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.4.4 Main Business/Business Overview
        4.4.5 Prestige Brands News
    4.5 Perrigo
        4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.5.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.5.2.1 Type 1
            4.5.2.2 Type 2
        4.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.5.4 Main Business/Business Overview
        4.5.5 Perrigo News
    4.6 Actavis
        4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.6.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.6.2.1 Type 1
            4.6.2.2 Type 2
        4.6.3 Actavis Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.6.4 Main Business/Business Overview
        4.6.5 Actavis News
    4.7 Reckitt Benckier
        4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.7.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.7.2.1 Type 1
            4.7.2.2 Type 2
        4.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.7.4 Main Business/Business Overview
        4.7.5 Reckitt Benckier News
    4.8 Tyratech
        4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.8.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.8.2.1 Type 1
            4.8.2.2 Type 2
        4.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.8.4 Main Business/Business Overview
        4.8.5 Tyratech News
    4.9 Shionogi
        4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.9.2 Head Lice Infestation Drug Product Types, Application and Specification
            9.9.2.1 Type 1
            9.9.2.2 Type 2
        4.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.9.4 Main Business/Business Overview
        4.9.5 Shionogi News
    4.10 TecLabs
        4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.10.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.10.2.1 Type 1
            4.10.2.2 Type 2
        4.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.10.4 Main Business/Business Overview
        4.10.5 TecLabs News
    4.11 Arborpharma
        4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.11.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.11.2.1 Type 1
            4.11.2.2 Type 2
        4.11.3 Arborpharma Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.11.4 Main Business/Business Overview
        4.11.5 Arborpharma News
    4.12 Major Pharmaceuticals
        4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.12.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.12.2.1 Type 1
            4.12.2.2 Type 2
        4.12.3 Major Pharmaceuticals Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.12.4 Main Business/Business Overview
        4.12.5 Major Pharmaceuticals News
    4.13 Logic Products
        4.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.13.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.13.2.1 Type 1
            4.13.2.2 Type 2
        4.13.3 Logic Products Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.13.4 Main Business/Business Overview
        4.13.5 Logic Products News
    4.14 Tianren
        4.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.14.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.14.2.1 Type 1
            4.14.2.2 Type 2
        4.14.3 Tianren Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.14.4 Main Business/Business Overview
        4.14.5 Tianren News
    4.15 ParaPRO
        4.15.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        4.15.2 Head Lice Infestation Drug Product Types, Application and Specification
            4.15.2.1 Type 1
            4.15.2.2 Type 2
        4.15.3 ParaPRO Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        4.15.4 Main Business/Business Overview
        4.15.5 ParaPRO News
5 United States Head Lice Infestation Drug Sales, Revenue (Value) by Type and Application (2012-2017)
    5.1 United States Head Lice Infestation Drug Sales, Revenue and Growth Rate (2012-2017)
    5.2 United States Head Lice Infestation Drug Sales, Revenue and Market Share by Type (2012-2017)
        5.2.1 United States Head Lice Infestation Drug Sales and Market Share by Type (2012-2017)
        5.2.2 United States Head Lice Infestation Drug Revenue and Market Share by Type (2012-2017)
        5.2.3 United States Head Lice Infestation Drug Price by Type (2012-2017)
    5.3 United States Head Lice Infestation Drug Sales and Market Share by Application (2012-2017)
6 Canada Head Lice Infestation Drug Sales, Revenue (Value) by Type and Application (2012-2017)
    6.1 Canada Head Lice Infestation Drug Sales, Revenue and Growth Rate (2012-2017)
    6.2 Canada Head Lice Infestation Drug Sales, Revenue and Market Share by Type (2012-2017)
        6.2.1 Canada Head Lice Infestation Drug Sales and Market Share by Type (2012-2017)
        6.2.2 Canada Head Lice Infestation Drug Revenue and Market Share by Type (2012-2017)
        6.2.3 Canada Head Lice Infestation Drug Price by Type (2012-2017)
    6.3 Canada Head Lice Infestation Drug Sales and Market Share by Application (2012-2017)
7 Mexico Head Lice Infestation Drug Sales, Revenue (Value) by Type and Application (2012-2017)
    7.1 Mexico Head Lice Infestation Drug Sales, Revenue and Growth Rate (2012-2017)
    7.2 Mexico Head Lice Infestation Drug Sales, Revenue and Market Share by Type (2012-2017)
        7.2.1 Mexico Head Lice Infestation Drug Sales and Market Share by Type (2012-2017)
        7.2.2 Mexico Head Lice Infestation Drug Revenue and Market Share by Type (2012-2017)
        7.2.3 Mexico Head Lice Infestation Drug Price by Type (2012-2017)
    7.3 Mexico Head Lice Infestation Drug Sales and Market Share by Application (2012-2017)
8 North America Head Lice Infestation Drug Market Forecast (2017-2022)
    8.1 North America Head Lice Infestation Drug Sales, Revenue Forecast (2017-2022)
    8.2 North America Head Lice Infestation Drug Sales, Sales Forecast by Countries (2017-2022)
    8.3 North America Head Lice Infestation Drug Sales Forecast by Type (2017-2022)
    8.4 North America Head Lice Infestation Drug Sales Forecast by Application (2017-2022)
    8.5 Head Lice Infestation Drug Price Forecast (2017-2022)
9 Head Lice Infestation Drug Manufacturing Cost Analysis
    9.1 Head Lice Infestation Drug Key Raw Materials Analysis
        9.1.1 Key Raw Materials
        9.1.2 Price Trend of Key Raw Materials
        9.1.3 Key Suppliers of Raw Materials
        9.1.4 Market Concentration Rate of Raw Materials
    9.2 Proportion of Manufacturing Cost Structure
        9.2.1 Raw Materials
        9.2.2 Labor Cost
        9.2.3 Manufacturing Expenses
    9.3 Manufacturing Process Analysis of Head Lice Infestation Drug
10 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10.1 Head Lice Infestation Drug Industrial Chain Analysis
    10.2 Upstream Raw Materials Sourcing
    10.3 Raw Materials Sources of Head Lice Infestation Drug Major Players in 2016
    10.4 Downstream Buyers
11 Marketing Strategy Analysis, Distributors/Traders
    11.1 Marketing Channel
        11.1.1 Direct Marketing
        11.1.2 Indirect Marketing
        11.1.3 Marketing Channel Development Trend
    11.2 Market Positioning
        11.2.1 Pricing Strategy
        11.2.2 Brand Strategy
        11.2.3 Target Client
    11.3 Distributors/Traders List
12 Market Effect Factors Analysis
    12.1 Technology Progress/Risk
        12.1.1 Substitutes Threat
        12.1.2 Technology Progress in Related Industry
    12.2 Consumer Needs/Customer Preference Change
    12.3 Economic/Political Environmental Change
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

North America and Europe Active Pharmaceutical Ingredients Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 103 | Code : MRS-216951 | 4480

This report studies the Active Pharmaceutical Ingredients market. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical sub Read more

North America and Europe Botox Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 108 | Code : MRS-216950 | 4480

Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. Scope of the Report: This report focuses on the Botox in North America and Euro Read more

EMEA (Europe, Middle East and Africa) Vegetable Capsules Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 124 | Code : MRS-214954 | 4480

Pill is a common part of many people’s lives for pharmaceutical use or as health Supplements, It has two main forms of tablets and capsules. Tablets were the most popular way to take medicine for quite some time. While since some characters such as hard to swallow and slice, too many additives and so on, most people tend to switch to capsules from the industrialization era on when capsule shells technologies and filling machines have been developed. Scope of the Report: This report fo Read more

EMEA (Europe, Middle East and Africa) Sugar Sphere Market Professional Survey Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 121 | Code : MRS-214864 | 4480

Sugar spheres are a widely used excipient for sustained-release pellet formulations. Sugar spheres (also called neutral pellets, nonpareil seeds, microgranules or sugar beads) are produced, preferably using a layered sugar-coating structure. The result is sugar spheres with sufficient mechanical stability for further processing. Scope of the Report: This report focuses on the Sugar Sphere Market Professional Survey in EMEA market, covering Europe, Middle East and Africa, This report c Read more

Global Active Pharmaceutical Ingredients Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 103 | Code : MRS-214050 | 3480

This report studies the Active Pharmaceutical Ingredients market. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical sub Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Gene Synthesis Market 2018 Forecast to 2023

Feb-2018 | Global Info Research | Pages : 105 | Code : MRS-214049 | 4880

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built. Sco Read more

Global Botox Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 108 | Code : MRS-214048 | 3480

Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. Scope of the Report: This report focuses on the Botox in global market, especia Read more

Global Pharmaceutical Hot Melt Extruder Market Research Report by Product Type, Application, Regions and Outlook 2017-2023

Jan-2018 | HeyReport | Pages : 77 | Code : MRS-213925 | 2030

Summary The global Pharmaceutical Hot Melt Extruder market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows: Read more

2018-2023 United States Neurofeedback System Market Report (Status and Outlook)

Feb-2018 | LPI (LP Information) | Pages : 89 | Code : MRS-213213 | 3360

In 2017, the Neurofeedback System market size was xx million in United States, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include BrainMaster Technologies BEE Medic Brainquiry Mitsar Thought Technology Mind Media Wearable Sensing Split by product types/category, covering Slow Cortical Potential Neurofeedback (SCP-NF) Low-energy Neurofeedback System (LENS) Hemo Read more

2018-2023 UK Neurofeedback System Market Report (Status and Outlook)

Feb-2018 | LPI (LP Information) | Pages : 89 | Code : MRS-213212 | 3360

In 2017, the Neurofeedback System market size was xx million in UK, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include BrainMaster Technologies BEE Medic Brainquiry Mitsar Thought Technology Mind Media Wearable Sensing Split by product types/category, covering Slow Cortical Potential Neurofeedback (SCP-NF) Low-energy Neurofeedback System (LENS) Hemoencephalographic (HEG) Read more

Single User | $(USD)4660 View Pricing